The study of utility of the reconstruction of common hepatic artery in pancreas transplantation

The study of utility of the reconstruction of common hepatic artery in pancreas transplantation - The study of utility of the reconstruction of common hepatic artery in pancreas transplantation

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027213

Enrollment

Registered

2017-05-01

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes melitus

Interventions

To reconstruct the common hepatic artery Do not rebuild the common hepatic artery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Renal transplant patient to be enforced in our hospital obtained the consent.

Exclusion criteria

Exclusion criteria: A drug allergy to Perflubutane, Those who have egg allergy, Those without adverse flow from the gastroduodenal artery by perfusion from the superior mesenteric artery.

Design outcomes

Primary

Measure	Time frame
A graft function, graft circulation at 1 month after transplantation.	—

Secondary

Measure	Time frame
A graft function, incidence of graft thrombus, graft survival at 3 month and 1 year after transplantation.	—

Countries

Japan

Contacts

Public ContactTaihei Ito

Fujita Health University Hospital Department of Organ Transplant Surgery

i-taihei@fujita-hu.ac.jp0562-93-2380

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026